Alexandra E. Riddell

University Place
Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Direct evidence implicating the asymmetrical dimethylarginine (ADMA)-dimethylarginine dimethylaminohydrolase 1 (DDAH1) pathway in cerebrovascular dysfunction and stroke pathogenesis in mice.

Direct evidence implicating the asymmetrical dimethylarginine (ADMA)-dimethylarginine dimethylaminohydrolase 1 (DDAH1) pathway in cerebrovascular dysfunction and stroke pathogenesis in mice.

Journal: British journal of pharmacology
Published: September 13, 2025

Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.

Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation.

Journal: The Journal of pharmacology and experimental therapeutics
Published: April 05, 2025

Identification of hypertension subtypes using microRNA profiles and machine learning.

Identification of hypertension subtypes using microRNA profiles and machine learning.

Journal: European journal of endocrinology
Published: June 17, 2024

SDMA as a marker and mediator in cerebrovascular disease.

SDMA as a marker and mediator in cerebrovascular disease.

Journal: Clinical science (London, England : 1979)
Published: June 06, 2024

A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.

A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.

Journal: British journal of pharmacology
Published: October 12, 2023

Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.

Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.

Journal: Cardiovascular research
Published: January 13, 2023

Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study.

Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study.

Journal: EBioMedicine
Published: March 08, 2022

CNS border-associated macrophages in the homeostatic and ischaemic brain.

CNS border-associated macrophages in the homeostatic and ischaemic brain.

Journal: Pharmacology & therapeutics
Published: December 11, 2021

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism.

Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism.

Journal: Cancers
Published: August 30, 2021

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.

Journal: Cardiovascular research
Published: May 14, 2021

Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model.

Regulation of connexin 43 by interleukin 1β in adult rat cardiac fibroblasts and effects in an adult rat cardiac myocyte: fibroblast co-culture model.

Journal: Heliyon
Published: October 16, 2019

RUNX1: an emerging therapeutic target for cardiovascular disease.

RUNX1: an emerging therapeutic target for cardiovascular disease.

Journal: Cardiovascular research
Published: September 30, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026